2008 annual financial data
Regeneron Pharmaceuticals 2008 Operating margin
Direct answer
Operating margin was -37.67%.
Operating income was -89,830,000 USD and net income was -82,710,000 USD.
Operating cash flow was -89,086,000 USD.
Get free Regeneron Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 238,457,000 USD
- Operating income
- -89,830,000 USD
- Net income
- -82,710,000 USD
- Operating cash flow
- -89,086,000 USD